CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer-Reference-Cited by-同舟云学术

CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer

Published:2018-07-27 Issue:7 Volume:16 Page:e2005869
ISSN:1545-7885
Container-title:PLOS Biology
language:en
Short-container-title:PLoS Biol

Author:

Chen Weilong,Qin Yuanyuan,Wang Dong,Zhou Lei,Liu Yin,Chen Sheng,Yin Liang,Xiao Yaoxing,Yao Xiao-Hong,Yang Xiaoli,Ma Wei,Chen Weifeng,He Xueyan,Zhang Lixing,Yang Qifeng,Bian Xiuwu,Shao Zhi-ming,Liu Suling^ORCID

Publisher

Public Library of Science (PLoS)

Subject

General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference36 articles.

1. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women;CE DeSantis;CA-Cancer J Clin,2016

2. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27;EP Mamounas;J Clin Oncol,2012

3. Cancer drug resistance: an evolving paradigm;C Holohan;Nat Rev Cancer,2013

4. Triple-negative breast cancer: an unmet medical need;CA Hudis;Oncologist,2011

5. Therapy-induced senescence in cancer. JNCI;JA Ewald;J Natl Cancer I,2010

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole transcriptome sequencing indicated the Anti-tumor immunity of NLRP3 in breast cancer;Genomics;2024-09

2. To investigate the function of age-related genes in different subtypes of asthma based on bioinformatics analysis;Heliyon;2024-08

3. IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer;Cancer Research;2024-04-24

4. Zinc finger protein 639 expression is a novel prognostic determinant in breast cancer;2024-04-03

5. A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy;Neoplasia;2024-03